Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats.
Cisplatin (Cpt) is known to induce a high level of oxidative stress, resulting in an increase of reactive oxygen species damaging the inner ear and causing hearing loss at high frequencies. Studies on animal models show that antioxidants may lower Cpt-induced ototoxicity. The aim of this study is to...
Main Authors: | Laura Astolfi, Edi Simoni, Filippo Valente, Sara Ghiselli, Stavros Hatzopoulos, Milvia Chicca, Alessandro Martini |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5025172?pdf=render |
Similar Items
-
Correction: Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats.
by: Laura Astolfi, et al.
Published: (2017-01-01) -
Dietary supplementation of coenzyme Q10 plus multivitamins to hamper the ROS mediated cisplatin ototoxicity in humans: A pilot study
by: Felice Scasso, et al.
Published: (2017-02-01) -
Liquid Crystalline Nanoparticles Conjugated with Dexamethasone Prevent Cisplatin Ototoxicity In Vitro
by: Filippo Valente, et al.
Published: (2022-11-01) -
Cisplatin ototoxicity histopathology
by: Sarah E. Hodge, et al.
Published: (2021-08-01) -
The Effects of Riluzole on Cisplatin-induced Ototoxicity
by: Selin Üstün Bezgin, et al.
Published: (2019-03-01)